Kit for detecting novel bunyavirus and application thereof

By combining specific primer pairs, crRNA, and Cas12a protein with a trans-cleavage reporter molecule, a novel Bunyavirus was detected with high sensitivity and specificity, solving the problem of insufficient detection sensitivity in existing technologies and making it suitable for use in resource-limited locations.

CN118910334APending Publication Date: 2024-11-08DAISHAN COUNTY CENT FOR DISEASE CONTROL & PREVENTION

Patent Information

Application Number
CN202411404873.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-10
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing CRISPR nucleic acid detection methods have low sensitivity when used for novel Bunyavirus (SFTSV), making it difficult to achieve high sensitivity and specificity detection.

Method used

Using specific primer pairs (SEQ ID NO.6 and SEQ ID NO.7) and crRNA (SEQ ID NO.11), combined with VA-type Cas proteins such as Cas12a, and in conjunction with trans-cleavage reporter molecules such as 8C-FQ, a two-step CRISPR nucleic acid detection method was performed.

Benefits of technology

It achieves 100% detection rate at low copy numbers (12.5 copies/test), has high sensitivity and specificity, avoids false positive results, and is easy to operate with low requirements for equipment and personnel.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910334A_ABST
    Figure CN118910334A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of virus detection, and discloses a kit for detecting a novel bunyavirus and application of the kit. The kit comprises a nucleic acid amplification unit and a CRISPR nucleic acid detection unit, the nucleic acid amplification unit comprises a primer pair, and the CRISPR nucleic acid detection unit comprises crRNA, Cas protein and trans-cleavage reporter molecules; the sequence of the crRNA is as shown in SEQ ID NO.11, and the primer pair comprises an upstream primer as shown in SEQ ID NO.6 and a downstream primer as shown in SEQ ID NO.7. The invention further discloses a kit for detecting the crRNA. According to the kit disclosed by the invention, a specific primer pair and crRNA are adopted, so that relatively high detection sensitivity and accuracy can be realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of virus detection, and in particular to a kit for detecting a novel bunyavirus and an application thereof. Background Art

[0002] Severe fever with thrombocytopenia syndrome bunyavirus (SFTSV), also known as the "new bunyavirus", causes fever with thrombocytopenia syndrome (SFTS) in humans. Its main clinical manifestations are high fever, thrombocytopenia, leukopenia, gastrointestinal symptoms and high mortality. Therefore, rapid detection of the virus in environmental and clinical samples is extremely important.

[0003] CRISPR nucleic acid detection usually refers to nucleic acid detection using the trans-cleavage activity of Cas protein, referred to as trans-CRISPR nucleic acid detection. Cas12 and Cas13 can specifically recognize the corresponding targets under the mediation of crRNA and trigger trans-cleavage activity, that is, non-specifically cut any nearby single-stranded oligonucleotides (there are also reports that single-stranded nucleic acid analogs are also cut in this way). The elements required for trans-CRISPR nucleic acid detection include Cas protein, guide RNA and trans-cleavage reporter molecules. The core of trans-CRISPR nucleic acid detection is still the base pairing principle, that is, the guide sequence of the guide RNA is paired with the target nucleic acid. The role of the Cas protein is that it can bind to the direct repeat sequence (DR) of the guide RNA. At the same time, after the guide sequence of the guide RNA is paired with the target nucleic acid, the trans-cleavage activity can be activated.

[0004] At present, there are few reports on CRISPR nucleic acid detection methods for SFTSV, and the detection sensitivity is low. For example, patent CN117867167A discloses a primer set and its application for detecting new bunyavirus based on RPA-CRISPR / Cas12a, and its minimum detection copy number is 10 copies / μL. Summary of the invention

[0005] In order to solve the technical problem of low sensitivity of the existing CRISPR nucleic acid detection method for the novel bunyavirus (SFTSV), the present invention provides a kit for detecting the novel bunyavirus and its application. The kit of the present invention uses a specific primer pair and crRNA, which can achieve high detection sensitivity and accuracy.

[0006] The specific technical scheme of the present invention is: In the first aspect, the present invention provides a kit for detecting a new type of Bunyavirus, comprising a nucleic acid amplification unit and a CRISPR nucleic acid detection unit, the nucleic acid amplification unit comprising a primer pair, the CRISPR nucleic acid detection unit comprising crRNA, Cas protein and a trans-cleavage reporter molecule; the sequence of the crRNA is shown in SEQ ID NO.11, and the primer pair comprises an upstream primer shown in SEQ ID NO.6 and a downstream primer shown in SEQ ID NO.7.

[0007] In the process of using CRISPR nucleic acid detection technology for virus detection, the design of primer pairs used for nucleic acid amplification and crRNA used for CRISPR nucleic acid detection will affect the detection sensitivity. However, the factors involved in the impact of primer pair and crRNA design on sensitivity are complicated. At present, no clear systematic rules have been summarized to show what kind of primer pairs and crRNA can achieve higher detection sensitivity. Its predictability is very poor, which brings great technical difficulties to the design of primer pairs and crRNA.

[0008] The present invention uses a specific primer pair (SEQ ID NO.6 and SEQ ID NO.7) and a crRNA with a specific sequence (SEQ ID NO.11), which has high sensitivity and high specificity when detecting the new bunyavirus (SFTSV). When the primer pair and crRNA are not designed properly, they will have an adverse effect on the detection sensitivity.

[0009] Preferably, the trans-cleavage reporter molecule is 5'- / 6-FAM / CCCCCCCC / BHQ1 / -3'.

[0010] The two ends of the above-mentioned trans-cleavage reporter molecule, namely the CCCCCCCC sequence, are respectively connected to 6-carboxyfluorescein (6-FAM) and the black hole quencher BHQ1.

[0011] In combination with the specific primer pair and crRNA used in the present invention, when the above-mentioned trans-cleavage reporter molecule is used, a higher fluorescence intensity can be obtained, thereby further improving the detection sensitivity.

[0012] Preferably, the Cas protein is a VA type Cas protein.

[0013] Furthermore, the VA type Cas protein is Cas12a protein.

[0014] Further, the Cas12a protein is FnCas12a, LbCas12a, ErCas12a, Evcas12a, Lb5Cas12a, HkCas12a, OsCas12a, TsCas12a, BbCas12a, BoCas12a, Lb4Cas12a, CeCas12a, PrCas12a, CsbCas12a, BhCas12a, SsCas12a, Lb3Cas12a, BpCas12a, PdCas12a, BfCas12a, PcCas12a, cMtCas12a, PeCas12a, LiCas12a, Lb2Cas12a, PmCas12a, MbCas12a, EeCas12a, CsbCas12a, ArCas12a, BsCas12a, AbCas12a and one or more of AsCas12a.

[0015] Preferably, the nucleic acid amplification system further comprises a transcriptase, a nucleic acid amplification enzyme, dNTPs and a buffer.

[0016] Furthermore, the nucleic acid amplification enzyme is a nucleic acid amplification enzyme in recombinase polymerase amplification technology (Recombinase Polymerase Amplification, RPA), recombinase mediated chain replacement nucleic acid amplification technology (Recombinase Aided Amplification, RAA), enzymatic recombinase isothermal amplification technology (Enzymatic Recombinase Amplification, ERA) or multienzyme isothermal rapid amplification technology (Multienzyme Isothermal Rapid Amplification, MIRA).

[0017] In a second aspect, the present invention provides the use of the kit in the detection of novel bunyaviruses for non-diagnostic purposes, comprising the following steps: (1) preparing a nucleic acid amplification mixture comprising a primer pair; (2) preparing a CRISPR nucleic acid detection mixture containing crRNA, Cas protein and trans-cleavage reporter molecule; (3) Mixing the sample to be tested with the nucleic acid amplification mixture, performing nucleic acid amplification, and obtaining an amplification product; (4) Mixing the amplified product with the CRISPR nucleic acid detection mixture to obtain a mixed system and reacting it.

[0018] The kit of the present invention can be used for SFTSV detection for diagnostic purposes (such as detection of clinical samples), and can also be used for SFTSV detection for non-diagnostic purposes (such as detection of environmental samples other than human and animal bodies).

[0019] The primer pair and crRNA system of the present invention are used in combination with the above method to detect SFTSV, which can achieve a shorter detection time while ensuring detection accuracy (high sensitivity and high specificity).

[0020] Preferably, steps (3) and (4) are performed in the same reaction tube; a liquid storage chamber is provided under the tube cover of the reaction tube; the specific process of steps (3) and (4) comprises: adding the nucleic acid amplification mixture and the sample to be tested into the tube body of the reaction tube, adding the CRISPR nucleic acid detection mixture into the liquid storage chamber, performing nucleic acid amplification, and contacting the obtained amplification product with the CRISPR nucleic acid detection mixture to react.

[0021] The above is a one-tube two-step CRISPR nucleic acid detection method, which performs nucleic acid amplification and CRISPR nucleic acid detection in the same reaction tube without opening the cover for sample addition. It can not only avoid aerosol contamination, but also improve the specificity of isothermal amplification detection by using CRISPR technology, avoiding the risk of false positive results. In addition, it has the advantages of not requiring more professional equipment or more professional personnel to operate, and is suitable for promotion in places with limited resources.

[0022] Furthermore, the obtained amplification product is contacted with the CRISPR nucleic acid detection system by centrifugation, inversion and / or shaking.

[0023] Preferably, in step (4), in the mixed system, the content of Cas protein is not less than 500 nmol / L, the content of crRNA is not less than 500 nmol / L, and the content of trans-cleavage reporter molecule is 62.5~500 nmol / L.

[0024] Preferably, in step (1), the content of the primer pair in the nucleic acid amplification mixture is 0.1-1 μM.

[0025] Preferably, in step (3), magnesium acetate is added to the nucleic acid amplification mixture before nucleic acid amplification.

[0026] Preferably, in step (3), the temperature for nucleic acid amplification is 37-42°C, and the time is 10-30 min; in step (4), the temperature for reaction is 37-48°C, and the time is 5-15 min.

[0027] Furthermore, in step (4), the reaction temperature is 45-48°C.

[0028] Compared with the prior art, the present invention has the following advantages: (1) The present invention uses a specific primer pair, crRNA and trans-cleavage reporter molecule, which are used in combination to achieve high sensitivity and specificity in the detection of SFTSV. After testing, using the above system, when the copy number of the analyte is as low as 12.5 copies / test (i.e., 2.5 copies / μL), 100% detection can still be achieved.

[0029] (2) The present invention uses a specific primer pair, crRNA and trans-cleavage reporter molecule, combined with a one-tube two-step CRISPR nucleic acid detection method, which can ensure detection accuracy while completing detection in a shorter time.

[0030] (3) The present invention adopts a one-tube two-step CRISPR nucleic acid detection method, which can avoid aerosol contamination and improve the specificity of isothermal amplification detection, thereby avoiding the problem of false positives. At the same time, it is easy to operate and has low requirements for equipment and operators. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 Schematic diagram of the process of detecting SFTSV in the present invention.

[0032] Figure 2 Figure 2 shows the SFTSV amplification results using different primer pairs.

[0033] Figure 3 This is a graph showing the SFTSV detection results of different crRNAs.

[0034] Figure 4 This is a graph showing the results of SFTSV detection using the trans-cleavage reporter molecule 8A-FQ.

[0035] Figure 5 This is a graph showing the SFTSV detection results using the trans-cleavage reporter molecule 8T-FQ.

[0036] Figure 6 This is a graph showing the results of SFTSV detection using the trans-cleavage reporter molecule 8G-FQ.

[0037] Figure 7 This is a graph showing the results of SFTSV detection using the trans-cleavage reporter molecule 8C-FQ.

[0038] Figure 8 This is a graph showing the SFTSV detection results for different Cas protein and crRNA dosages.

[0039] Fig. 9 It is an analysis diagram of the sensitivity test results of the SFTSV detection system of the present invention.

[0040] Fig.10 This is a graph showing the specificity test results of the SFTSV detection system of the present invention.

[0041] Remark: Figure 4~Figure 7 In the figure, except for the curve indicated by the arrow "NTC" which is the negative control test result without adding template, the other curves are the test results with adding template; Figure 6 In the experiment, the negative control (NTC) without template addition overlaps with the test result curve with template addition. DETAILED DESCRIPTION

[0042] The present invention is described below by specific examples. It should be understood that these examples are only used to illustrate the present invention and are not used to limit the scope of the present invention. Without departing from the spirit and scope of the inventive concept, changes and advantages that can be thought of by those skilled in the art are included in the present invention, and the attached claims and any equivalents thereof are the protection scope of the present invention.

[0043] The "one-tube two-step CRISPR nucleic acid detection" described in the following embodiments is referred to as "one-tube two-step method", also known as "one-tube two-step CRISPR detection", "CRISPR one-tube two-step nucleic acid detection", "CRISPR one-tube two-step nucleic acid detection", "CRISPR one-tube two-step detection", "CRISPR one-tube two-step method", which means that nucleic acid amplification and CIRSPR nucleic acid detection are performed step by step in the same container. In the following embodiments, the process of "one-tube two-step CRISPR nucleic acid detection" is as follows Figure 1 As shown, the container used is a reaction tube (RT basic reaction unit), the sample to be tested (template) and the part for nucleic acid amplification (denoted as "Buffer A") are arranged in the tube body of the reaction tube, and the part for CRISPR nucleic acid detection (denoted as "Buffer B") is arranged on the tube cover of the reaction tube and is located on the side facing the tube body of the reaction tube. After the sample to be tested contacts with Buffer A, Buffer B is made to fall into the tube body of the reaction tube by centrifugation, inversion and / or shaking, so that the sample to be tested contacts with Buffer B.

[0044] In the following examples, the models and sources of the instruments and reagents used are shown in Table 1 and Table 2, but the protection scope of the present invention is not limited thereto.

[0045] Table 1 Instruments

[0046] Table 2 Reagents

[0047] Example 1: Selection of SFTSV detection targets The S1 gene of the novel bunyavirus (SFTSV) (sequence shown in SEQ ID NO.1, denoted as "SFTSV_S") was selected as the specific detection target of the virus. The specific conserved sequence region of the S1 gene was selected as the detection region, and the T7 promoter sequence was added before the conserved sequence to facilitate the subsequent in vitro transcription of RNA, and the plasmid pUC57-SFTSV_S containing the SFTSV_S sequence was constructed.

[0048] The size of pUC57-SFTSV_S plasmid is: 2710 bp + 966 bp = 3676 bp.

[0049] The concentration of the plasmid diluted in 100 μL Tris-EDTA buffer (TE buffer) was measured by Qubit. The average concentration was 31.7 ng / μL, and the calculated concentration was 7.99×10 9 copies / μL.

[0050] Example 2: Comparison of amplification effects of primer pairs 2.1 Primer pairs The three primer pairs in Table 3 are all directed to the SFTSV-specific detection target determined in Example 1 (such as the SFTSV_S sequence shown in SEQ ID NO.1).

[0051] Table 3 Primers for SFTSV nucleic acid amplification

[0052] 2.2 Comparison of primer pair amplification effects Prepare the reaction system according to Table 4 below, flick to mix, centrifuge briefly to collect the reagents to the bottom of the tube, then add it to the RT basic reaction unit (provided with the RT-RAA nucleic acid amplification kit), flick the RT basic reaction unit gently to allow the lyophilized powder to fully dissolve evenly, then centrifuge briefly to collect the reagents to the bottom of the tube. Finally, open the reaction unit, add 5 μL of magnesium acetate to the cap of each RT reaction unit, and then add 5 μL of template to the RT reaction unit.

[0053] Table 4 SFTSV nucleic acid amplification system

[0054] The reaction procedure was: constant temperature at 37°C, reaction time was 30 min. The S gene IVT transcribed RNA of SFTSV was used as a template (in the following examples, unless otherwise specified, the templates were all S gene IVT transcribed RNA of SFTSV), and nucleic acid amplification was performed using the three primer pairs in Table 3. The nucleic acid amplification products were subjected to agarose gel electrophoresis and photographed for analysis. The results are shown in Figure 2 .according to Figure 2It can be seen that the nucleic acid amplification product of primer pair SFTSV-3 has the highest brightness in the electrophoresis gel band, indicating that SFTSV-3 has a better amplification effect on the SFTSV specific detection target. In the following examples, unless otherwise specified, the primer pair uses SFTSV-3.

[0055] Example 3: Comparison of crRNA detection effects 3.1 crRNA The targets of the 17 crRNAs in Table 5 are all within the amplified fragment range of the primer pair SFTSV-3. In Table 5, the uracil in the RNA shown in SEQ ID NO.8~24 is represented by the letter "U" commonly used in the art; in the sequence table file, according to the ST.26 standard, the uracil in the RNA shown in SEQ ID NO.8~24 is represented by the letter "T", which has the same meaning as the letter "U" in the sequence in Table 1.

[0056] Table 5 CRISPR nucleic acid detection crRNA of SFTSV

[0057] 3.2 crRNA preparation The Cas12a High Yield crRNA Synthesis and Purification Kit (Cat. No. 31904, ToloBio) from ToloBio was used to perform in vitro transcription and purification of crRNA. Cas12a Sense Oligo, Anneal Buffer, TranscriptMax Reaction Buffer, NTP Mix, TranscriptMax Enzyme Mix, DNase I Buffer, and DNase I are included in the kit. The specific process is as follows: (1) Preparation of DNA transcription template: The Cas12a Sense Oligo in the Cas12a efficient crRNA synthesis and conversion kit was annealed and extended with the SFTSV_S-crRNA-R series primers shown in Table 6. The annealing extension system and procedure adopted are shown in Tables 7 and 8, respectively. After the reaction is completed, it can be used as a DNA transcription template for each crRNA in Table 5.

[0058] Table 6 SFTSV_S-crRNA-R series primers

[0059] Table 7 Annealing extension system

[0060] Table 8 Annealing and extension program

[0061] (2) In vitro transcription of crRNA: The reaction system was prepared according to Table 9.

[0062] Table 9 crRNA in vitro transcription reaction system

[0063] The reaction system prepared according to Table 9 was thoroughly mixed, and then centrifuged briefly to collect the reagents at the bottom of the tube, and incubated at 37°C for 12 h for in vitro transcription.

[0064] After the 37°C incubation, prepare 30 μL of DNase I reaction solution according to Table 10 and add it to 20 μL of in vitro transcription product to remove the DNA template in the transcription system. The DNase I reaction conditions are: 37°C, 30 min.

[0065] Table 10 DNase I reaction solution

[0066] (3) Magnetic bead purification of crRNA transcription products: 1) First, take the magnetic beads out of the 4℃ refrigerator and place them at room temperature for about 30 minutes to allow the temperature to equilibrate to room temperature. Invert or vortex to mix the magnetic beads thoroughly, pipette 25 μL of magnetic beads and 50 μL of isopropanol into 50 μL of crRNA sample to be purified, and mix thoroughly by pipetting.

[0067] 2) Incubate at room temperature for 5 min to allow the RNA to bind to the magnetic beads.

[0068] 3) Place the sample on a magnetic rack for 5 min. After the solution is clear, carefully remove the supernatant.

[0069] 4) Keep the sample on the magnetic rack, add 200 μL of freshly prepared 80% ethanol to rinse the magnetic beads, incubate at room temperature for 30 s, and carefully remove the supernatant.

[0070] 5) Repeat step 4) and rinse twice in total.

[0071] 6) Keep the sample on the magnetic rack and air-dry the magnetic beads for 5 minutes with the lid open.

[0072] 7) Remove the sample from the magnetic rack, add 50 μL of nuclease-free water, pipette to mix thoroughly, and let stand at room temperature for 5 min.

[0073] 8) Place the sample on a magnetic rack for 5 minutes. After the solution is clarified, carefully transfer the supernatant to a new nuclease-free PCR tube to obtain the purified crRNA.

[0074] 3.3 Comparison of crRNA detection effects The SFTSV one-tube two-step CRISPR nucleic acid detection system was used. On the basis of nucleic acid amplification of SFTSV using primer pair SFTSV-3, the detection effects of each crRNA in Table 5 were compared. The specific process is as follows: According to Table 11 and Table 12, prepare the part for nucleic acid amplification (recorded as "Buffer A") and the part for CRISPR nucleic acid detection (recorded as "Buffer B"), flick to mix, centrifuge briefly to collect the reagent at the bottom of the tube, and then add it to the RT basic reaction unit. Gently flick the RT basic reaction unit to allow the lyophilized powder to fully dissolve evenly, and then centrifuge briefly to collect the reagent at the bottom of the tube. Open the RT basic reaction unit, then slowly add 5 μL of magnesium acetate and 5 μL of template along the inner wall of each reaction unit, and use a pipette tip to mix (make sure Buffer B does not fall to the bottom of the tube).

[0075] Table 11 Detection system - Buffer A (crRNA comparison)

[0076] Table 12 Detection system - Buffer B (crRNA comparison)

[0077] The reaction procedure is: constant temperature at 37°C, reaction time is 20 min. After the reaction is completed, take out the reaction tube and place it in a handheld centrifuge for a short centrifugation, then put it into a constant temperature device, constant temperature at 48°C, open the FAM channel to read the fluorescence, and the reaction time is 10 min.

[0078] Results Figure 3 .according to Figure 3 It can be seen that the effect of SFTSV_S-crRNA4 is better than other crRNAs. When the crRNA is used for SFTSV detection, higher sensitivity and accuracy can be achieved. In the following embodiments, unless otherwise specified, crRNA uses SFTSV_S-crRNA4.

[0079] Example 4: Comparison of detection effects of trans-cleavage reporter molecules (probes) The SFTSV one-tube two-step CRISPR nucleic acid detection system was used to compare the detection effects of the four trans-cleavage reporter molecules in Table 13. The specific process is as follows: According to Table 14 and Table 15, prepare the part for nucleic acid amplification (referred to as "Buffer A") and the part for CRISPR nucleic acid detection (referred to as "Buffer B"), flick to mix, centrifuge briefly to collect the reagent at the bottom of the tube, and then add it to the RT basic reaction unit. Gently flick the RT basic reaction unit to allow the lyophilized powder to fully dissolve evenly, and then centrifuge briefly to collect the reagent at the bottom of the tube. Open the RT basic reaction unit, then slowly add 5 μL of magnesium acetate and 5 μL of template along the inner wall of each reaction unit, and use a pipette tip to mix (make sure Buffer B does not fall to the bottom of the tube).

[0080] Table 13 Trans-cleavage reporter molecules

[0081] Table 14 Detection system - Buffer A (comparison of trans-cleavage reporter molecules)

[0082] Table 15 Detection system - Buffer B (comparison of trans-cleavage reporter molecules)

[0083] The reaction procedure is: constant temperature at 37°C, reaction time is 20 min. After the reaction is completed, take out the reaction tube and place it in a handheld centrifuge for a short centrifugation to collect the reagent at the bottom of the tube, then put it into a constant temperature device, constant temperature at 48°C, open the FAM channel to read the fluorescence, and the reaction time is 10 min.

[0084] Results Figure 4~Figure 7 .according to Figure 4~Figure 7 It can be seen that among the four trans-cleavage reporter molecules in Table 13, 8C-FQ has the highest fluorescence intensity, indicating that it can achieve higher sensitivity and accuracy when used for SFTSV detection. In the following examples, unless otherwise specified, the probe used is 8C-FQ.

[0085] Example 5: Effect of SFTSV one-tube two-step CRISPR nucleic acid detection under different Cas protein and crRNA dosages According to Table 16 and Table 17, prepare the part for nucleic acid amplification (recorded as "Buffer A") and the part for CRISPR nucleic acid detection (recorded as "Buffer B"), flick to mix, centrifuge briefly to collect the reagent at the bottom of the tube, and then add it to the RT basic reaction unit. Gently flick the RT basic reaction unit to allow the lyophilized powder to fully dissolve evenly, and then centrifuge briefly to collect the reagent at the bottom of the tube. Open the RT basic reaction unit, then slowly add 5 μL of magnesium acetate and 5 μL of template along the inner wall of each reaction unit, and use a pipette tip to mix (make sure Buffer B does not fall to the bottom of the tube).

[0086] Table 16 Detection system - Buffer A (different Cas protein and crRNA dosage)

[0087] Table 17 Detection system - Buffer B (different Cas protein and crRNA dosage)

[0088] The reaction procedure is: constant temperature at 37°C, reaction time is 20 min. After the reaction is completed, take out the reaction tube and place it in a handheld centrifuge for a short centrifugation to collect the reagent at the bottom of the tube, then put it into a constant temperature device, constant temperature at 48°C, open the FAM channel to read the fluorescence, and the reaction time is 10 min.

[0089] Results Figure 8 .from Figure 8 It can be seen from the results that in the mixed system consisting of Buffer A+Buffer B+Template+Magnesium acetate, the fluorescence intensity is highest when the concentrations of crRNA and Cas12a are both 500 nM, which is the optimal dosage of Cas protein and crRNA in the SFTSV one-tube two-step CRISPR nucleic acid detection system. In the following examples, unless otherwise specified, the concentrations of crRNA and Cas12a are both 500 nM.

[0090] Example 6: Sensitivity and specificity test of SFTSV one-tube two-step CRISPR nucleic acid detection 6.1 SFTSV one-tube two-step CRISPR nucleic acid detection system and method According to Table 18 and Table 19, prepare the part for nucleic acid amplification (recorded as "Buffer A") and the part for CRISPR nucleic acid detection (recorded as "Buffer B"), flick to mix, centrifuge briefly, and then add them to the RT basic reaction unit. Gently flick the RT basic reaction unit to allow the lyophilized powder to fully dissolve evenly, and then centrifuge briefly to collect the liquid to the bottom of the tube. Open the RT basic reaction unit, then slowly add 5 μL of magnesium acetate and 5 μL of template along the inner wall of each reaction unit, and use a pipette tip to mix (make sure Buffer B does not fall to the bottom of the tube).

[0091] Table 18 SFTSV one-tube two-step CRISPR nucleic acid detection system - Buffer A

[0092] Table 19 SFTSV one-tube two-step CRISPR nucleic acid detection system - Buffer B

[0093] The reaction procedure is: constant temperature at 37°C, reaction time is 20 min. After the reaction is completed, take out the reaction tube and place it in a handheld centrifuge for a short centrifugation, then put it into a constant temperature device, constant temperature at 48°C, open the FAM channel to read the fluorescence, and the reaction time is 10 min.

[0094] 6.2 Sensitivity test The pUC57-SFTSV_S plasmid was transcribed in vitro, and the obtained RNA template was quantified and tested according to the gradient concentration of 100 copies / test, 50 copies / test, 25 copies / test, 12.5 copies / test, 6.25 copies / test, and 3.125 copies / test (the above "copies / test" means the number of RNA template copies obtained by in vitro transcription of the pUC57-SFTSV_S plasmid used in each test). The specific process is as follows: Using the above gradient concentration RNA template, the test was performed according to "6.1 SFTSV one-tube two-step CRISPR nucleic acid detection system and method". Each concentration was tested with 8 replicates.

[0095] The statistical results of the detection rates at each concentration are shown in Table 20 and Fig. 9 According to Table 20 and Fig. 9 It can be seen that when the copy number of the analyte is 12.5 copies / test, the SFTSV detection system of the present invention can still achieve a 100% detection rate, indicating that it has a high sensitivity.

[0096] Table 20 Sensitivity test results

[0097] 6.3 Specificity test RNA extracted from the following six viruses was used as samples: Chikungunya virus, Influenza B virus, Hepatitis C virus, Hemorrhagic fever virus, Dengue virus, and Norovirus. A negative control (NTC, no template added) and a positive control (the transcribed RNA of the SFTSV_S gene obtained after transcription using the pUC57-SFTSV_S plasmid was used as a template) were set up. Tests were performed according to "5.1 SFTSV one-tube two-step CRISPR nucleic acid detection system and method".

[0098] Results Fig.10 .according to Fig.10 It can be seen that the SFTSV detection system of the present invention has good specificity and can avoid interference from various other viruses.

[0099] Example 7: Application of SFTSV one-tube two-step CRISPR nucleic acid detection in real sample testing 7.1 One-tube two-step CRISPR nucleic acid detection method According to Table 21 and Table 22, prepare the part for nucleic acid amplification (recorded as "Buffer A") and the part for CRISPR nucleic acid detection (recorded as "Buffer B"), flick to mix, centrifuge briefly, and then add them to the RT basic reaction unit. Gently flick the RT basic reaction unit to allow the lyophilized powder to fully dissolve evenly, and then centrifuge briefly to collect the liquid to the bottom of the tube. Open the RT basic reaction unit, and then slowly add 5 μL of magnesium acetate and 5 μL of template (RNA extracted from real samples) along the inner wall of each reaction unit, and use a pipette tip to mix (make sure Buffer B does not fall to the bottom of the tube).

[0100] Table 21 SFTSV one-tube two-step CRISPR nucleic acid detection system-Buffer A (real sample detection)

[0101] Table 22 SFTSV one-tube two-step CRISPR nucleic acid detection system-Buffer B (real sample detection)

[0102] The reaction procedure is: constant temperature at 37°C, reaction time is 20 min. After the reaction is completed, take out the reaction tube and place it in a handheld centrifuge for a short centrifugation, then put it into a constant temperature device, constant temperature at 48°C, open the FAM channel to read the fluorescence, and the reaction time is 10 min.

[0103] 7.2 Test results The 31 collected real samples were tested using a one-tube two-step CRISPR nucleic acid detection method. The results are shown in Table 23, where "+" indicates a positive test result and "-" indicates a negative test result.

[0104] Table 23 Test results of real samples

[0105] Unless otherwise defined, all technical terms and scientific terms used in the present invention have the same meanings as those commonly understood by ordinary technicians in the field to which the present disclosure belongs. Unless otherwise specified, the raw materials and equipment used in the present invention are conventional raw materials and equipment in the field and can be obtained from conventional commercial channels; unless otherwise specified, the methods used in the present invention are conventional methods in the field.

[0106] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent transformation made to the above embodiment based on the technical essence of the present invention still falls within the protection scope of the technical solution of the present invention.

Claims

1. A kit for detecting a novel bunyavirus, characterized in that: It includes a nucleic acid amplification unit and a CRISPR nucleic acid detection unit, the nucleic acid amplification unit includes a primer pair, and the CRISPR nucleic acid detection unit includes crRNA, Cas protein and a trans-cleavage reporter molecule; the sequence of the crRNA is shown in SEQ ID NO.11, and the primer pair includes an upstream primer shown in SEQ ID NO.6 and a downstream primer shown in SEQ ID NO.

7.

2. The kit according to claim 1, characterized in that The trans-cleavage reporter molecule is 5'- / 6-FAM / CCCCCCCC / BHQ1 / -3'.

3. The kit according to claim 1, characterized in that The Cas protein is a VA type Cas protein.

4. The kit according to claim 3, characterized in that The VA type Cas protein is Cas12a protein.

5. The kit according to claim 1, characterized in that The nucleic acid amplification system further comprises a transcriptase, an enzyme for nucleic acid amplification, dNTPs and a buffer.

6. The kit according to claim 5, characterized in that The nucleic acid amplification enzyme is an enzyme used in recombinase polymerase amplification technology, recombinase-mediated chain replacement nucleic acid amplification technology, enzymatic recombination isothermal amplification technology or multi-enzyme constant temperature rapid amplification technology.

7. Use of the kit according to claim 1 in the detection of novel bunyaviruses for non-diagnostic purposes, characterized in that: The following steps are involved: (1) preparing a nucleic acid amplification mixture comprising a primer pair; (2) preparing a CRISPR nucleic acid detection mixture containing crRNA, Cas protein and trans-cleavage reporter molecule; (3) Mixing the sample to be tested with the nucleic acid amplification mixture, performing nucleic acid amplification, and obtaining an amplification product; (4) Mixing the amplified product with the CRISPR nucleic acid detection mixture to obtain a mixed system and reacting it.

8. The use according to claim 7, characterized in that: Steps (3) and (4) are performed in the same reaction tube; a liquid storage chamber is provided under the tube cover of the reaction tube; the specific process of steps (3) and (4) includes: adding the nucleic acid amplification mixture and the sample to be tested into the tube body of the reaction tube, adding the CRISPR nucleic acid detection mixture into the liquid storage chamber, performing nucleic acid amplification, and contacting the obtained amplification product with the CRISPR nucleic acid detection mixture to react.

9. The use according to claim 7, characterized in that: In step (4), in the mixed system, the content of Cas protein is not less than 500 nmol / L, the content of crRNA is not less than 500 nmol / L, and the content of trans-cleavage reporter molecule is 62.5~500 nmol / L.

10. The use according to claim 7, characterized in that: In step (3), magnesium acetate is added to the nucleic acid amplification mixture before nucleic acid amplification.

Citation Information

Patent Citations

  • Reagent kit for detecting new Bunyavirus by real-time fluorescent RT-PCR (reverse transcription-polymerase chain reaction)

    CN102634604A

  • Isothermal amplification detection kit and detection method of new bunyavirus

    CN104561375A

  • Detection kit for severe fever with thrombocytopenia syndrome virus (SFTSV)

    CN106191307A

  • CrRNA for detecting novel bunyavirus, CRISPR-Cas12a system and application

    CN113755646A

  • Primer group for detecting new bunyavirus based on RPA-CRISPR / Cas12a and application of primer group

    CN117867167A

Cited By

  • CRISPR-Cas12b (clustered regularly interspaced short palindromic repeats-CRISPR-Cas12b) temperature control one-step method pathogen nucleic acid

    CN119464574A

  • Sequence combination, kit and method for co-detecting new bunyavirus and anaplasma phagocytophilum based on RPA-CRISPR and application

    CN121737357A

  • Compositions and methods for detecting severe fever and thrombocytopenia syndrome virus

    EP4831302A1